Tuesday, March 18, 2014
ACTC the future in bio-tech: Clinical Trial Hold Of Geron's Revolutionary Drug ...
ACTC the future in bio-tech: Clinical Trial Hold Of Geron's Revolutionary Drug ...: •The clinical hold does not currently affect the Mayo sponsored Myelofibrosis clinical trial. •EV patients had been on treatment for an aver...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment